what does a glp-1 do How Injections Help with Medical Weight Loss? Why are GLP-1 agonists being
Description
& Okovityi, S
Patients receiving semaglutide (0.5 or 1.0 mg) for 104 weeks demonstrated a significantly higher risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or required procedural treatment compared to those receiving placebo (HR, 1.76
Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Sustainable success in the Obesity Medicine market will not just be about assets or portfolios of assets, but also active influence across the full patient weight loss and weight maintenance journey, which will mean new partnerships between emergent actors (digital health platforms, patients themselves)
June 13, 2022
